(2-Ethylbenzofuran-3-yl)(4-hydroxyphenyl)methanone; Vasoc; Fragivix; Fagivil; Methanone, (2-ethyl-3-benzofuranyl)(4-hydroxyphenyl)-; 2-Ethyl-3-(4-hydroxybenzoyl)benzofuran; 2-Ethyl-3-benzofuranyl p-hydroxyphenyl ketone; UNII-23ZW4BG89C; NSC 82134; L 2197; 2-Ethyl-3-(p-hydroxybenzoyl)benzofuran; 2-Ethyl-4'-hydroxy-3-benzoylbenzofuran; KETONE, 2-ETHYL-3-BENZOFURANYL p-HYDROXYPHENYL; (2-ethyl-1-benzofuran-3-yl)-(4-hydroxyphenyl)methanone; 23ZW4BG89C; Benzaron; CHEMBL1474963; Fragivil; Benzofuran, (2-ethyl-3-(4'-hydroxybenzoyl)); NSC82134; (2-Ethyl-1-benzofuran-3-yl)(4-hydroxyphenyl)methanone; Venagil; Benzaronum; Benzarona; Benzarone [INN:DCF]; Benzaronum [INN-Latin]; Benzarona [INN-Spanish]; L 2197-Labaz; Benzofuran, [2-ethyl-3-(4'-hydroxybenzoyl)]; EINECS 216-026-2; L 2179-Labaz; BRN 0222901; 2-Ethyl-3-(4'-hydroxybenzoyl)benzofuran; Ethyl-2 (hydroxy-4 benzoyl)-3 benzofuranne [French]; Ethyl-2 (hydroxy-4 benzoyl)-3 benzofuranne; ZINC71; NCIOpen2_004472; 5-18-02-00334 (Beilstein Handbook Reference); MLS006010019; SCHEMBL555497; (2-ethylbenzofuran-3-yl)-(4-hydroxyphenyl)methanone; DTXSID2061721; EX-A1132; WLN: T56 BOJ C2 DOR DQ; 2-Ethyl-3-p-hydroxybenzoylbenzofuran; BDBM50342278; MFCD00867417; NSC-82134; AKOS016010825; MCULE-4948029211; AK115955; AS-18081; SMR001550644; UNM000003519301; W0011; C14474; 477B196; SR-01000945019; (2-ethyl-3-benzofuranyl)(4-hydroxyphenyl)methanone; [[4-(1-methyl-1-phenylethyl)phenoxy]methyl]-oxiran; SR-01000945019-1; Q27116149; (2-Ethylbenzo[b]furan-3-yl)(4-hydroxyphenyl)methanone; (2-Ethylbenzofuran-3-yl)(4-hydroxyphenyl)methanone (Benzarone)